Thrombotic complications during cancer treatment in children

Experimental Oncology

Volumn 29, Issue 3, 2007, Pages 231-235

  Lipay, N V ^a   Dmitriev, V V ^a   Borisenok, M B ^a  

^a National Center of Pediatric Oncology and Hematology   (Belarus)

Author keywords

Cancer; Children; Factor V Leiden; MTHFR C677T; Prothrombin G20210A; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; CANCER THERAPY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; CATHETERS, INDWELLING; CHILD; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMOBILIZATION; MALE; MUTATION; NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RETROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOSIS;

EID: 36749074512     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Prandoni P, Piccioli A, Girolami A. Cancer and venous thromboembolism: an overview. Hematologica 1999; 84: 437-45.
2. Lee A, Levine M. Venous thromboembolism and cancer: risk and outcomes. Circulation 2003; 107: 17-21.
3. Falanga A, Vignoli A. Venous thromboembolism in oncology. Exp Oncol 2004; 26: 11-4.
4. Sitzman TB. Prevention of perioperative deep vein thrombosis and pulmonary embolism. Mayo: Jakonsville medicine, 1998. 7 pp.
5. Siragusa S, Anastasio R, Giarratano A, Malato A, Bonifacio G, Arcara C, Gebbia N. Managing of cancer patients with acute thromboembolism: exploring safe alternatives to hospitalization. Exp Oncol 2004; 26: 192-5.
6. Sorensen HT, Mellemkjar L, Jorgen HO, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med 2000; 343: 1846-50.
7. Khorana AA, Rrancis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 2007; 5: 632-4.
8. Seligsohn U, Lubecky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344: 1222-30.
9. Bick RL. Hereditary and acquired thrombophilic disorders. Appl Thromb Hemost 2006; 12: 125-35.
10. Zoller B, de Frutos PG, Hillarp A, Dahlback B. Thrombophilia as multigenetic disease. Haematologica 1999; 84: 59-70.
11. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: 4-8.
12. Athale U, Chan A. Thrombosis in children with acute lymphoblastic leukemia. Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy. Thromb Res 2003; 111: 199-212.
13. Caruso V, Jacoviello L, Di Castelnuovo A, Storti S, Donati MB. Venous thrombotic complications in adults undergoing iduction treatment for acute lymphoblastic leukemia: results from a meta-analysis. J Thromb Haemost 2007; 5: 621-3.
14. Caufman PB, Wu W, Kim D, Cseke LJ. Handbook of molecular and cellular methods in biology and medicine. London: CRC Press, 1995. 484 pp.
15. Nassiruddin Z, Masood A, Suhaib A. Frequency of factor V Leiden mutation. JCPSP. 2005; 15: 15-7.
16. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
17. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijmans LAJ, van del Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
18. Schmitz C, Lindpaintner K, Verhoef P. Genetic Polymorphism of Methylenetetrahydrofolate Reductase and Myocardial Infarction. Circulation 1996; 94: 1812-4.
19. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, Donati MB. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood 2006; 108: 2216-22.
20. Athale UH, Chan AK. Thromboembolic complications in paediatric hematologic malignancies. Semin Thromb Hemost 2007; 33: 41626.
21. Sifontes MT, Nuss R, Hunger SP, Wilimas J, Jacobson LJ, Manco-Johnson MJ. The factor V Leiden mutation in children with cancer and thrombosis. BrJ Haematol 1997; 96: 484-9.
22. Ravin AJ, Edwards RP, Krohn MA, Kelley JR, Christopherson WA, Roberts JM. The factor Leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients. Obstetr Gynecol 2002; 100: 1285-9.
23. Varga EA, Sturm AC, Misita CP, Moll S. Homocysteine and MTHFR mutations: Relation to thrombosis and coronary artery disease. Circulation 2005; 111: 289-93.
24. Gurgey A, Asian D. Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Haematol Oncol 2001; 23: 159-64.
25. Di Micco P, De Lucia D, De Vita F, Niglio A, Di Micco G, Martinelli E, Chirico G, D'Uva M, Torella R. Acquared cancer-related thrombophilia testified by increase levels of prothrombin fragment 1+2 and D-dimer in patients affected by solid tumors. Exp Oncol 2002; 24: 108-11.
26. Massicotte P, Mitchell L. Thromboprophylaxis of central venous lines in children with cancer: the first steps taken on the long road ahead. Acta Paediatr 2006; 95: 1049-52.
27. Athale U, Cox S, Siciliano S, Chan AK. Thromboembolism in children with sarcoma. Pediatr Blood Cancer 2007; 49: 171-6.